Examining lymph node dissection methods for small lung nodules

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of various lymph node dissection techniques on the prognosis of ground glass nodules (GGNs) that are smaller than 3 cm and contain more than 50% solid components. It involves multiple centers and aims to determine the most effective surgical approach for improving patient outcomes. Participants will undergo lobectomy and will be monitored for their prognosis following the procedure. The study focuses on patients whose GGNs have not subsided after three months of observation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Aged between 18 and 75 years;
2. GGO is diagnosed by lung CT and failure to subside after 3 months (the patient having been re-examined by thin-section CT);
3. The maximum diameter of the GGO is smaller than 3cm;
4. The maximum diameter of the solid component in the GGO is more than 50%;
5. The patient is able to undergo the lobectomy
6. The patient is able to understand and comply with the study and has provided written informed consent.

Exclusion Criteria:

\-

Patients meeting any of the following criteria are not eligible for this trial:

1. Patients with a history of using immunosuppressive or hormonal drugs;
2. Patients receiving radiotherapy or chemotherapy;
3. Patients who fail to comply with our follow-up strategy;
4. Other situations that are not in conformity with the standards and requirements of this trial.

Where it's running

• Jiang Wei
  Shanghai, China Recruiting

Study contacts

• Study coordinator: Jiang Wei, Dr
• Email: jiang.wei1@zs-hospital.sh.cn
• Phone: 86-21-64041990

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Screening for heart failure in older adults with atrial fibrillation in rural China

  We’re testing whether HF screening in 65–80 year olds with AF in rural China can help identify heart failure early and track progression over time.

  Recruiting Jiangsu Taizhou People's Hospital · Taizhou, Jiangsu · NCT07611084

• Skipping the clinical target volume (CTV) around the primary tumor in limited-stage small cell lung cancer

  This trial tests whether giving chest radiotherapy that skips the usual extra margin around the main tumor is as effective and causes fewer side effects for people with limited-stage small cell lung cancer who have responded to initial chemotherapy.

  Recruiting at 2 sites Phase 3 Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT07008716

• Comparing two doses of Everolimus for treating neuroendocrine tumors

  This study is testing whether a lower dose of Everolimus can effectively treat patients with advanced neuroendocrine tumors while causing fewer side effects compared to a higher dose.

  Recruiting at 2 sites Phase 2 AC Camargo Cancer Center · São Paulo, São Paulo and 1 other locations · NCT06472388

• Testing a new guide for monitoring labor and childbirth in Norway

  This study is testing a new guide for monitoring labor and childbirth to see if it can improve care and reduce unnecessary interventions for mothers and babies in Norway.

  Recruiting at 9 sites Ostfold Hospital Trust · Nordbyhagen, Akershus and 9 other locations · NCT05791630

• Using targeted radiation therapy for patients with limited progression of kidney cancer on immune therapy

  This study is testing if a special type of radiation therapy can help people with kidney cancer who are seeing limited growth while on immune therapy feel better and live longer.

  Recruiting Phase 2 Yale University · New Haven, Connecticut · NCT04974671

• Evaluating ablation therapy for lung cancer with ground-glass nodules

  This study is testing if a special treatment called ablation therapy can help people with lung cancer that shows up as ground-glass nodules when they can't have regular surgery.

  Recruiting Phase 2 Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT04905056

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.